Henry Schein, Inc. (HSIC)

Henry Schein, Inc. (HSIC) stock has fluctuated in the past six months due to earnings reports and market sentiment, with prices ranging from $61.95 to $89.29 over the past year. On May 5, 2026, the company reported strong first-quarter results, exceeding EPS and revenue estimates, but the stock dipped 5.5% the following week. Management reaffirmed its full-year 2026 guidance, projecting sales growth of 3% to 5% and non-GAAP diluted EPS between $5.23 and $5.37. A light flu season impacted the medical segment's performance in Q1 2026. The company repurchased 1.6 million shares for $125 million during the quarter. Analyst ratings are mixed, with some firms issuing "Buy" ratings and others maintaining a "Neutral" stance.

Demand for Henry Schein's products and services experiences seasonality, particularly in the medical segment. The demand for point-of-care diagnostic test products is affected by the severity of the flu season, as seen in Q1 2026. The dental market remains healthy, with demand outpacing supply and Dental Service Organizations (DSOs) gaining market share.

Henry Schein, Inc. is a major American distributor of healthcare products and services for office-based dental and medical practitioners, operating in the Medical Equipment, Supplies & Distribution industry. It offers dental products and equipment, medical equipment, and services like management software, financial services, training, maintenance, and equipment repair. The company's business is divided into Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments.

Henry Schein, Inc. is headquartered in Melville, New York, and has a significant global presence. It operates or has affiliates in 33 countries and territories, serving healthcare practitioners in over 190 countries and regions. The United States accounts for 69% of its net sales.

Henry Schein has a strong brand reputation, consistently recognized for its ethical practices and social responsibility. It has been named one of the "World's Most Ethical Companies®" by Ethisphere for 15 years. The company has launched initiatives like "Practice Green" and supports the American Dental Association's Give Kids A Smile Program. No significant negative events affecting the brand were found in the past year.

Henry Schein, Inc.'s ownership is largely institutional, with institutional investors holding approximately 87.2% of the shares as of March 31, 2025. Key institutional shareholders include Vanguard Group Inc., Kohlberg Kravis Roberts & Co. L.P., BlackRock, Inc., Artisan Partners Limited Partnership, JPMorgan Chase & Co., State Street Corp., and Invesco Ltd. Individual investors hold about 10% of the shares, while company insiders own around 5%, with individual insiders accounting for approximately 1.2% of shares.